Collateral for a security interest recorded Oct 9, 2020 (Midcap Funding IV Trust).
Term ends Oct 29, 2034 · High confidence
20-year base term ends Oct 29, 2034
Held by Patheon Softgels Inc.
Filed Oct 29, 2014 as application 14/527,201 · Granted Feb 20, 2018
Base term plus 78 days of patent term adjustment (USPTO delay) · capped by a resolved terminal disclaimer
Today
2014
2034
Clock starts
Oct 29, 2014
Oct 29, 2014
Term ends
Oct 29, 2034
Oct 29, 2034
Granted
Feb 20, 2018
Feb 20, 2018
base term
fee events
Updated Nov 14, 2026 · includes USPTO assignment & status data published Nov 14, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
78
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
Capped
Terminal disclaimer
Resolved from the filed document, referencing US 9,895,333.
2 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
31
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.
This patent's term runs 78 days past its 20-year base term on prosecution delay. A terminal disclaimer resolved from the filed document caps it earlier. 2 of 3 maintenance fees are paid so far. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Oct 29, 2014, when this application, 14/527,201, was filed | Oct 29, 2034 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | +78 days, USPTO patent term adjustment record | Jan 15, 2035 | High confidence |
| Terminal disclaimer cap | Disclaimer resolved from the filed document (refs US 9,895,333) | capped to Oct 29, 2034 | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 2 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Oct 29, 2034 | High confidence |
This family
| US 9,895,332 | this patent Oct 2034 | Oct 2034 |
| Application PCT/US2014/062892 | PCT application no patent term | no patent term |
| US 9,326,965 | In force Feb 2035 | Feb 2035 |
| Application PCT/US2015/017893 | PCT application no patent term | no patent term |
| Application 62/138,468 | Pending not computed | not computed |
| US 9,895,333 | In force Oct 2034 | Oct 2034 |
| Application PCT/US2015/037558 | PCT application no patent term | no patent term |
| US 9,326,947 | In force Feb 2035 | Feb 2035 |
8 of 31 applications in this family shown, earliest filings first. The applications whose file history this site holds. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Nov 19, 2014 Reel 34204, frame 318 | Zhang, Peijin; Fatmi, Aqeel A | Banner Life Sciences LLC | Assignment of Assignor's Interest |
| Nov 19, 2014 Reel 34294, frame 916 | Banner Pharmacaps Inc. | Banner Life Sciences LLC | Nunc Pro Tunc Assignment |
| Mar 5, 2015 Reel 35133, frame 328 | Banner Life Sciences LLC | UBS AG, Stamford Branch, as Collateral Agent | Security Interest |
| Jul 31, 2015 Reel 36239, frame 188 | UBS AG, Stamford Branch | Banner Life Sciences LLC | Release of Security Interest |
| Dec 4, 2015 Reel 37211, frame 968 | Bionpharma Healthcare LLC (as Licensee from Banner Life Sciences, LLC) | Midcap Financial Trust, As Agent | Security Interest (REVOLVER) |
| Dec 4, 2015 Reel 37212, frame 135 | Bionpharma Healthcare LLC (as Licensee from Banner Life Sciences, LLC) | Midcap Financial Trust, As Agent | Security Interest (TERM) |
| Jan 4, 2016 Reel 37399, frame 659 | Bionpharma Inc.; Bionpharma Healthcare LLC | Athyrium Opportunities II Acquisition LP | Security Interest |
| Jun 29, 2017 Reel 43032, frame 619 | Banner Life Sciences LLC | Patheon Softgels Inc. | Nunc Pro Tunc Assignment |
| Oct 9, 2020 Reel 54036, frame 121 | Bionpharma Healthcare LLC (as Licensee from Patheon Softgels Inc.) | Midcap Financial Trust, As Agent | Security Interest (TERM) |
| Oct 9, 2020 Reel 54036, frame 260 | Bionpharma Healthcare LLC (as Licensee from Patheon Softgels Inc.) | Midcap Funding IV Trust, as Agent | Amended and Restated Security Interest (REVOLVING) |
| Dec 8, 2020 Reel 54575, frame 365 | Athyrium Opportunities II Acquisition LP | Bionpharma Inc.; Bionpharma Healthcare LLC | Release of Security Interest |
| Dec 8, 2020 reel/frame not recorded | Athyrium Opportunities II Acquisition LP | Bionpharma Inc. | Release of Security Interest |
| Dec 8, 2020 reel/frame not recorded | Athyrium Opportunities II Acquisition LP | Bionpharma Healthcare LLC | Release of Security Interest |
| Feb 1, 2021 Reel 55100, frame 105 | Midcap Financial Trust | Bionpharma Healthcare LLC; Bionpharma Health Inc.; Bionpharma Inc. | Release of Security Interest |
| Feb 1, 2021 reel/frame not recorded | Midcap Financial Trust | Bionpharma Healthcare LLC | Release of Security Interest |
| Feb 1, 2021 reel/frame not recorded | Midcap Financial Trust | Bionpharma Health Inc. | Release of Security Interest |
| Feb 1, 2021 reel/frame not recorded | Midcap Financial Trust | Bionpharma Inc. | Release of Security Interest |
| Apr 18, 2022 Reel 59622, frame 59 | Bionpharma Healthcare LLC (as Licensee) | WXM LLC | Security Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
What's changing
Oct 2034
Term ends Oct 29, 2034. Maintenance fees still fall due before then
Note
The 78 days of patent term adjustment (USPTO delay) are read from the USPTO record, not recalculated by us
Disclaimer cap
This term is capped by a terminal disclaimer resolved from the filed document, referencing US 9,895,333.
Citations
9
later US patents cite this one
That is above the median of utility patents granted in 2018 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.